Video Experimental Relacionado
Updated: Sep 10, 2025
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
26.5K
¿Necesitamos medicamentos para los síntomas psiquiátricos específicamente para la enfermedad de Parkinson?
Kelly A Mills1, Gregory M Pontone2,3
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of Parkinson's disease
|August 21, 2025
Resumen
El desarrollo de nuevos medicamentos para los síntomas psiquiátricos en personas con enfermedad de Parkinson (EP) requiere una mayor atención a los objetivos del tratamiento. Esta revisión examina los tratamientos farmacológicos actuales y propone direcciones futuras para mejorar las terapias.
Área de la Ciencia:
- La neurociencia
- La psiquiatría
- Farmacología
Sus antecedentes:
- Los síntomas psiquiátricos son muy frecuentes en las personas con enfermedad de Parkinson (PWP), que a menudo aparecen en la fase prodroma.
- Estos síntomas están intrincadamente relacionados con las deficiencias motoras y sus tratamientos, lo que sugiere posibles conexiones mecánicas.
Objetivo del estudio:
- Revisar los tratamientos farmacológicos existentes para los síntomas psiquiátricos en pacientes con PWP.
- Explorar futuras estrategias y objetivos para el desarrollo de nuevos medicamentos para los síntomas psiquiátricos en la EP.
Principales métodos:
- Revisión de la literatura de las pruebas actuales para los tratamientos farmacológicos.
- Exploración de posibles vínculos mecánicos entre los síntomas psiquiátricos y motores.
Principales resultados:
- Se discuten los tratamientos farmacológicos actuales para los síntomas psiquiátricos en PWP.
- Se destaca la compleja interacción entre los síntomas psiquiátricos, los síntomas motores y los tratamientos.
Conclusiones:
- Se necesitan más investigaciones sobre las conexiones mecanicistas.
- Los nuevos objetivos y enfoques terapéuticos son esenciales para desarrollar medicamentos efectivos para los síntomas psiquiátricos de la enfermedad de Parkinson.
Videos de Conceptos Relacionados
01:24Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
380
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
380
01:15Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:28Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
01:28Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97